Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-11 @ 8:59 AM
Study NCT ID:
NCT02747732
Status:
UNKNOWN
Last Update Posted:
2019-04-23
First Post:
2016-04-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
Sponsor:
Meirav Kedmi MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12
Start Date Type:
None
Primary Completion Date:
2020-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-10
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-20
First Submit QC Date:
None
Study First Post Date:
2016-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-21
Last Update Post Date:
2019-04-23
Last Update Post Date Type:
ACTUAL